Investigating genetic factors that influence cancer risk and outcomes
Official title: DCEG- Genotyping for epidemiology studies
Funded at Leidos Biomedical Research, INC. · NIH-11219746 · Data updated 2026-11-12
This study is looking at how our genes might affect the risk of getting cancer and how it progresses, and if you choose to participate, you could help us learn more by sharing a small sample of your genetic material, which could lead to better ways to prevent and treat cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 28, 2024 |
| Project end | August 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $17,547,387 |
| NIH project number | 75N91019D00024-0-759102400011-4 |
| Project ID | NIH-11219746 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals with a family history of cancer or those diagnosed with specific types of cancer who are willing to provide genetic samples.
✕Less likely to help
Patients who do not have a genetic predisposition to cancer or are not diagnosed with cancer may not benefit from this research.
What this research studies
This research focuses on understanding how genetic variations contribute to the risk and outcomes of various cancers. By collaborating with experts in epidemiology and biostatistics, the team conducts extensive genome-wide studies to identify heritable factors associated with cancer. The research also includes analyzing tumor and normal tissue samples to compare genetic information, which helps in understanding cancer development. Patients may have the opportunity to contribute to this research by providing genetic samples, which could lead to better cancer prevention and treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of cancer susceptibility and more personalized treatment options for patients.
How similar studies have gone: Previous research has successfully identified genetic markers associated with cancer risk, indicating that this approach has potential for meaningful discoveries.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.